Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase–producing Enterobacterales bloodstream infections (REDUCE-BSI)

OBJECTIVE: To re-examine the use of noncarbapenems (NCBPs), specifically piperacillin-tazobactam (PTZ) and cefepime (FEP), for extended-spectrum beta-lactamase–producing Enterobacterales bloodstream infections (ESBL-E BSIs). DESIGN: Retrospective cohort study. SETTING: Tertiary-care, academic medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Catherine H., Venugopalan, Veena, Santevecchi, Barbara A., Voils, Stacy A., Ramphal, Reuben, Cherabuddi, Kartikeya, DeSear, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615022/
https://www.ncbi.nlm.nih.gov/pubmed/36310806
http://dx.doi.org/10.1017/ash.2022.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615022/
https://www.ncbi.nlm.nih.gov/pubmed/36310806
http://dx.doi.org/10.1017/ash.2022.21

Ejemplares similares